Partnership review
Public partnership inquiries and pilot offers are paused.
This route no longer collects names, work email addresses, organizations, roles, phone numbers, messages, patient counts, research proposals, or letters of intent. Partnership, research, pilot, and commercial discussions require a reviewed scope and an approved non-sensitive contact process before reopening.
Public clinician workflows are paused
This route does not display a patient roster, patient detail, clinical summary, processor inventory, security attestation, submitted inquiry, partnership offer, or operational clinician workspace. It collects and transmits no information.
Current source boundary
- Retrospective self-reported wellness context only.
- No public clinician or patient-data collection.
- No public roster, summary, export, credential upload, or cohort report.
- No predictive, diagnostic, treatment, monitoring, or emergency representation.
Evidence still required
- Deployed processors, regions, data routes, logs, retention, backups, export, and deletion.
- Authenticated authorization, role, consent, isolation, and audit testing.
- Versioned notices and qualified privacy, legal, clinical, claims, security, and regulatory review.
- Post-deployment verification tied to the exact released commit.
Do not send sensitive information
Public channels are limited to general business questions. Do not send patient, health, medical, diagnosis, treatment, insurance, credential, license, or other sensitive information.